Diversified Trust’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$469K Buy
2,212
+754
+52% +$148K 0.01% 776
2026
Q1
$286K Sell
1,458
-49
-3% -$9.52K 0.01% 862
2025
Q4
$262K Buy
+1,507
New +$274K ﹤0.01% 870
2023
Q2
Sell
-2,089
Closed -$296K 845
2023
Q1
$296K Buy
2,089
+598
+40% +$85.6K 0.01% 627
2022
Q4
$233K Buy
+1,491
New +$214K 0.01% 681
2022
Q1
Sell
-2,512
Closed -$435K 826
2021
Q4
$435K Sell
2,512
-51
-2% -$7.76K 0.01% 503
2021
Q3
$372K Sell
2,563
-362
-12% -$53K 0.01% 506
2021
Q2
$386K Sell
2,925
-771
-21% -$101K 0.01% 477
2021
Q1
$474K Buy
+3,696
New +$455K 0.02% 387

Other funds holding DGX

Diversified Trust's DGX Position: Q2 2026 in Review

Diversified Trust increased its Quest Diagnostics (DGX) stake by 52% in Q2 2026, buying an estimated $148K and bringing the position to 2,212 shares worth $469K. The position accounts for 0.01% of the portfolio, ranked #776.

Diversified Trust first reported a position in DGX in Q1 2021 and has held it in 9 quarters since. The position peaked at $474K in Q1 2021. 207 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Diversified Trust held 2,212 shares of Quest Diagnostics worth $469K as of Q2 2026.
  • Diversified Trust bought 754 Quest Diagnostics shares in Q2 2026, an estimated $148K.
  • Quest Diagnostics made up 0.01% of Diversified Trust's portfolio in Q2 2026, its #776 holding.
  • Diversified Trust first reported a position in Quest Diagnostics in Q1 2021 and has held it in 9 quarters since.
  • Diversified Trust's Quest Diagnostics position peaked at $474K in Q1 2021.
  • 207 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.